NCT01867255View on ClinicalTrials.gov

Study to Examine the Effect of Gastric Bypass Surgery on Venlafaxine ER Blood Levels

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Bariatric SurgeryGastric BypassRoux-en-Y Gastric Bypass
Interventions
DRUG

venlafaxine ER (extended-release) 75 mg

A single dose of venlafaxine ER 75 mg is to be administered once at each of two study visits, pre- and post-gastric bypass surgery.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER